Enterprise Value to EBITDA Ratio: capsovision.com (CV)

The market price confirmed by the chart demonstrates an EV/EBITDA of 0.00. CapsoVision Inc (CV) relies on global sales of wireless capsules for intestinal examinations, minimizing regional risks. A high technological barrier to entry protects the firm's position from simple imitations, while the unique panoramic view without external sensors guarantees physicians a detailed image and maximum patient comfort.

CV CapsoVision: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/10/2026

capsovision.com - analytical breakdowns and key metrics (CV)

- current price and projected stock value:

Stock Price CapsoVision|CV - Consensus Target

- company stock exchange capitalization indicators:

Market Valuation CV|CV - Value Adjusted for Debt and Cash

- business book valuation details:

Net Assets per Single Share CapsoVision Inc|CV - Company Net Assets|Market Capitalization to Book Value Ratio capsovision.com|CV - Company Assets

- debt and solvency information:

- business earnings and investment ratios data:

CV - Company Net Income|Future Profit CapsoVision Inc|CV - Company Value to Net Income|Forward P/E Multiple CapsoVision|CV - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CV|CV - Operating profit before depreciation charges|Net earnings per share for the last 12 months CapsoVision Inc|CV - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth capsovision.com|CV - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year CapsoVision Inc

Comprehensive company analysis:CapsoVision Medical CV

Investors use this ratio to determine the real value of a business, stripped of the impact of taxes and depreciation. The metric compares the total enterprise value with its operating profit before interest and amortization. By analyzing the EV/EBITDA ratio of a company in a historical context, one can identify an undervalued asset. For CapsoVision Inc (CV), global demand for unique medical capsules minimizes geopolitical risks, stabilizing the fundamental value.

Competitors of CapsoVision Inc (CV)

EV/EBITDA Multiple ABT (Abbott Laboratories Inc.)|TMO - Enterprise Value to EBITDA Ratio|GEHC: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation MTD (mt.com)|Waters (WAT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Bio-Techne Corp|BRKR (Bruker Corp.) - EV/EBITDA Multiple|Company Value to EBITDA Brooks Automation AZTA|EV/EBITDA Multiple VREX|semlerscientific.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BFLY (Butterfly Network)|Total Company Value to Operating Income Before Depreciation Ratio Mesa Laboratories Inc (MLAB)|Quantum-Si Corp - EV/EBITDA Multiple|Nano-X Imaging Ltd (NNOX) - Enterprise Value to EBITDA Ratio|QTRX: EV/EBITDA Multiple|908devices.com (MASS) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MaxCyte|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RPID|Enterprise Value to EBITDA Ratio SEER (Seer Inc.)|HYPR (Hyperfine Medical) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple FONR (FONAR Corporation)|Daxor Corp (DXR) - Company Value to EBITDA|MDAI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Multiple Organovo Holdings (VIVS)|ACON (Aclarion Corp) - Enterprise Value to EBITDA Ratio|Akoya Biosciences, Inc. (AKYA) - EV/EBITDA Multiple|THMO (ThermoGenesis) - EV/EBITDA Multiple|Talis Biomedical Corp (TLIS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization T2 Biosystems (TTOO)